Alternative access routes: Private prescription: Available through private GPs, specialist weight management clinics, or online prescribing services, though costs are substantial Clinical trials: Some research studies recruit menopausal women, offering supervised access to these medications Diabetes indication: Women with type 2 diabetes may access GLP-1 receptor agonists through diabetes services according to NICE NG28 guidance [23] Patients should discuss their individual circumstances with their GP to determine eligibility and local access pathways
As more people experience reduced hunger and smaller portions on these medications, they also begin looking for solutions that feel less invasive or more affordable
Lyxumia: Summary of product characteristics
What side effects should I watch for with GLP-1 therapy and MS
What the First Expert Guidelines Say Written by: Christine Fallabel 7 minute read June 17, 2026 For years, people living with type 1 diabetes (T1D) have experienced insulin resistance, burnout, frustrating high blood sugar levels, weight gain and food cravings without much response from the medical community
